In the wake of the increase in Current Liabilities in the first quarter 2026, Quick Ratio fell to 0.22 below Earth Science Tech Inc average.

Within Major Pharmaceutical Preparations industry 473 other companies have achieved higher Quick Ratio than Earth Science Tech Inc in first quarter 2026. While Quick Ratio total ranking has improved so far during the Q1 2026 to 3378, from total ranking in the fourth quarter 2026 at 3706.

Explain Quick Ratio?
How much Cash & cash equivalents ETST�s has?
What are ETST�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ETST Quick Ratio	(Jun 30 2026) Q1	(Mar 31 2026) Q4	(Dec 31 2025) Q3	(Sep 30 2025) Q2	(Jun 30 2025) Q1
Y / Y Current Liabilities Change	-10.37 %	-35.52 %	122.19 %	114.56 %	129.11 %
Y / Y Cash & cash equivalent Change	-32.12 %	-56.01 %	156.17 %	-18.47 %	-33.53 %
Quick Ratio MRQ	0.22	0.39	0.58	0.37	0.29
ETST's Total Ranking	# 3378	# 3706	# 2986	# 3396	# 2322
Seq. Current Liabilities Change	43.02 %	-35.52 %	-7.25 %	4.79 %	2.89 %
Seq. Cash & cash equivalent Change	-20.79 %	-56.01 %	42.89 %	36.33 %	-48.67 %

Quick Ratio first quarter 2026 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 474
Healthcare Sector	# 909
Overall Market	# 3869

Quick Ratio Statistics
High	Average	Low
9.3	0.74	0
(Jun 30 2014)		(Sep 30 2022)

Financial Statements
Earth Science Tech Inc 's Current Liabilities	$ 3 Millions	Visit ETST's Balance sheet
Earth Science Tech Inc 's Cash & cash equivalent	$ 1 Millions	Visit ETST's Balance sheet
Source of ETST's Sales		Visit ETST's Sales by Geography

Cumulative Earth Science Tech Inc 's Quick Ratio

ETST's Quick Ratio for the trailling 12 Months

ETST Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	22.26 %	56.22 %	121.8 %	95.75 %	101.94 %
Y / Y Cash & cash equivalent TTM Growth	-9.92 %	-12.18 %	33.25 %	27.58 %	114.78 %
Quick Ratio TTM	0.39	0.41	0.45	0.42	0.53
Total Ranking TTM	# 2004	# 1818	# 1538	# 1734	# 1627
Seq. Current Liabilities TTM Growth	-2.84 %	-8.65 %	15.46 %	19.31 %	24.14 %
Seq. Cash & cash equivalent TTM Growth	-6.22 %	-17.43 %	23.42 %	-5.74 %	-8.57 %

Quick ratio ranking by company, industry and sector >> Back to ETST Financial Strength Comparisons >> Go to Compare ETST Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in ETST's Current Liabilities to $2.90 millions, cumulative Quick Ratio to 0.39 below the ETST average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 454 other companies have achieved higher Quick Ratio than Earth Science Tech Inc . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending fourth quarter 2026 at 3384.

Explain Quick Ratio?
How much Cash & cash equivalents ETST�s has?
What are ETST�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	# 455
Healthcare Sector	# 923
Within the Market	# 3378

trailing twelve months Quick Ratio Statistics
High	Average	Low
3.89	0.66	0
(Sep 30 2014)		(Dec 31 2021)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Eton Pharmaceuticals Inc	0.59	$ 26.845 Millions	$ 45.124 Millions
Kura Oncology Inc	0.59	$ 70.242 Millions	$ 118.193 Millions
Allarity Therapeutics Inc	0.59	$ 16.982 Millions	$ 28.579 Millions
Bristol myers Squibb Company	0.59	$ 11,067.000 Millions	$ 18,659.000 Millions
Prestige Consumer Healthcare Inc	0.58	$ 89.127 Millions	$ 153.806 Millions
Biora Therapeutics Inc	0.57	$ 21.906 Millions	$ 38.687 Millions
Matinas Biopharma Holdings Inc	0.56	$ 0.761 Millions	$ 1.350 Millions
Karyopharm Therapeutics Inc	0.56	$ 75.225 Millions	$ 134.233 Millions
Journey Medical Corp	0.56	$ 25.643 Millions	$ 45.770 Millions
Nektar Therapeutics	0.55	$ 39.267 Millions	$ 70.985 Millions
Supernus Pharmaceuticals inc	0.52	$ 180.145 Millions	$ 347.378 Millions
Citius Oncology Inc	0.50	$ 16.564 Millions	$ 33.152 Millions
Verrica Pharmaceuticals Inc	0.50	$ 11.198 Millions	$ 22.442 Millions
Aytu Biopharma Inc	0.48	$ 26.308 Millions	$ 54.659 Millions
Jupiter Neurosciences Inc	0.47	$ 1.522 Millions	$ 3.251 Millions
Aeon Biopharma inc	0.47	$ 3.431 Millions	$ 7.342 Millions
Evolus Inc	0.46	$ 45.170 Millions	$ 98.731 Millions
Biomarin Pharmaceutical Inc	0.45	$ 874.005 Millions	$ 1,927.164 Millions
Pds Biotechnology Corp	0.45	$ 5.596 Millions	$ 12.377 Millions
Biofrontera Inc	0.44	$ 4.659 Millions	$ 10.541 Millions
Beyondspring Inc	0.43	$ 10.361 Millions	$ 23.834 Millions
Organon and Co	0.43	$ 1,132.000 Millions	$ 2,616.000 Millions
Gossamer Bio Inc	0.41	$ 57.026 Millions	$ 137.783 Millions
Bausch Health Companies Inc	0.39	$ 1,825.000 Millions	$ 4,687.000 Millions
Johnson and Johnson	0.38	$ 21,094.000 Millions	$ 54,895.000 Millions
Ultragenyx Pharmaceutical Inc	0.36	$ 125.000 Millions	$ 351.000 Millions
Vanda Pharmaceuticals Inc	0.34	$ 56.119 Millions	$ 164.026 Millions
Ainos Inc	0.29	$ 1.423 Millions	$ 4.928 Millions
Elanco Animal Health Incorporated	0.29	$ 530.000 Millions	$ 1,852.000 Millions
Provectus Biopharmaceuticals Inc	0.27	$ 1.157 Millions	$ 4.234 Millions

Date modified: 2026-09-26T07:27:16+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.